Global law firm Greenberg Traurig, LLP represented Japan-based global specialty pharmaceutical
company ONO Pharmaceutical Co. in its acquisition of Waltham, Massachusetts-based Deciphera
Pharmaceuticals for $25.60 per share
in cash, for a total equity value of $2.4
billion.
WASHINGTON, April 30,
2024 /PRNewswire-PRWeb/ -- Global law firm
Greenberg Traurig, LLP represented Japan-based global specialty pharmaceutical
company ONO Pharmaceutical Co. in its acquisition of Waltham, Massachusetts-based Deciphera
Pharmaceuticals for $25.60 per share
in cash, for a total equity value of $2.4
billion.
The deal is expected to close in the third quarter of 2024,
subject to customary closing conditions and regulatory
approvals.
ONO said that as a wholly owned subsidiary Deciphera's research
and development capabilities in the cancer field and commercial
capabilities in the United States
and Europe will reinforce ONO's
pipeline and accelerate global development.
"It has been an honor to work with ONO, a 300-year-old company
with a strong innovative portfolio, and guide them through this
transaction that will help grow their capabilities to help those
diagnosed with cancer and other diseases around the globe," said
Chia-Feng Lu, a Washington, D.C., based Life Sciences and
Medical Technology shareholder who co-led the deal. "The scope of
this transaction, which involved multiple jurisdictions and a broad
array of highly complex corporate and regulatory work, demonstrates
the strength of Greenberg Traurig's global platform in life
sciences. I look forward to continuing our work with ONO in the
years to come."
You can learn more in ONO's press release here.
The Greenberg Traurig team was led by Lu and New York Corporate Shareholder Michael D. Helsel.
About Greenberg Traurig: Greenberg Traurig, LLP has more than
2750 attorneys in 47 locations in the
United States, Europe and
the Middle East, Latin America, and Asia. The firm is a 2022 BTI "Highly
Recommended Law Firm" for superior client service and is
consistently among the top firms on the Am Law Global 100 and NLJ
500. Greenberg Traurig is Mansfield Rule 6.0 Certified Plus by The
Diversity Lab. The firm is recognized for powering its U.S. offices
with 100% renewable energy as certified by the Center for Resource
Solutions Green-e® Energy program and is a member of the
U.S. EPA's Green Power Partnership Program. The firm is known for
its philanthropic giving, innovation, diversity, and pro bono. Web:
http://www.gtlaw.com.
Twitter
View original
content:https://www.prweb.com/releases/greenberg-traurig-represents-ono-pharmaceutical-co-in-2-4b-acquisition-of-deciphera-pharmaceuticals-302131863.html
SOURCE Greenberg Traurig